Sandbox Reserved 646: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 80: | Line 80: | ||
3. Long-term therapy - this treatment requires an extended time for a patient to follow a low-protein diet. In addition, he/she may take oral sodium benzoate or sodium phenylbutyrate. However this is guided by a physician. | 3. Long-term therapy - this treatment requires an extended time for a patient to follow a low-protein diet. In addition, he/she may take oral sodium benzoate or sodium phenylbutyrate. However this is guided by a physician. | ||
== '''References''' == | |||
Ash, David Structure and Function of Arginases [http://www.ncbi.nlm.nih.gov/pubmed/15465781 | |||
Roche, Victoria Improving Pharmacy Students' Understanding and Long-term Retention of Acid-Base Chemistry [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2690908/] | |||
Corporation, Worthington Biochemical. Arginase [http://http://www.worthington-biochem.com/AR/default.html] | |||
Perozich, John Roles of conserved residues in the arginase family [http://www.ncbi.nlm.nih.gov/pubmed/9507056] | |||
Morris Jr., S.M. Recent Advances in Arginine Metabolism: Roles and Regulation of the Arginases. Br. J. Pharmacol. 2009, 157, 922-930. | |||
Abumrad NN, Barbul A. The use of arginine in clinical practice. In: Cynober LA, editor. Metabolic and Therapeutic Aspects of Amino Acids in Clinical Nutrition. Boca Raton, FL: CRC Press; 2004. pp. 595–611 | |||
